Repurposing “Bad Cholesterol” to Precisely Target Inflammation in Atherosclerosis
Professor Lisa Volpatti developed a targeted approach that directs anti-inflammatory proteins to diseased arteries, reducing immune cell activity and improving therapeutic effectiveness.







